Unicorns Journal: Where Startup Stories Shine Bright

From top-tier biotech labs to building a company on immune persistence, Shubh Gupta is rewriting the playbook for solid tumor treatment. At Immumem Therapeutics, he’s betting on staying power, not just speed - and building therapies that don’t quit.

LovOn co-founder Sergey Bakaev shares the strategy that helped him raise a pre-seed round without any fundraising experience or investor network. We talked about how to survive dozens of rejections in a row, how to build a contact system from scratch, and why the strongest intros come from people you once helped yourself. You’ll learn whether any founder can raise a round, how to handle rejections properly, whether it’s possible to build a product and raise at the same time, and how the “density of communication” impacts fundraising outcomes.